Efficacy and Safety of Everolimus in Recipients of Heart Transplants to Prevent Acute and Chronic Rejection
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Everolimus
Related studies linked through entity extraction aliases.
Anti-Thymocyte Globulin, Cyclosporine, and RAD in Islet Transplantation
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Bevacizumab, Everolimus, and Erlotinib in Treating Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
RESCUE Study - Everolimus in Liver Transplantation Recipients With Renal Insufficiency
- Status
- COMPLETED
- Phase
- PHASE3
Everolimus in Treating Patients WIth Recurrent or Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy and Safety Study of Everolimus Plus Reduced Cyclosporine Versus Mycophenolic Acid Plus Cyclosporine in Kidney Transplant Recipients
- Status
- COMPLETED
- Phase
- PHASE3
Polymorphism of the Cytochrome P450-system in Renal Transplants
- Status
- COMPLETED
- Phase
- N/A
Everolimus for Treating Pediatric Patients With Recurrent or Refractory Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Everolimus in Combination With Cyclosporine Microemulsion in de Novo Renal Transplant Recipients
- Status
- COMPLETED
- Phase
- PHASE4
Everolimus Versus Mycophenolate Mofetil in Combination With Reduced Dose Cyclosporine Microemulsion in Maintenance Heart Transplant Recipients
- Status
- COMPLETED
- Phase
- PHASE4
Safety, Tolerability and Efficacy of Everolimus With Lower Versus Higher Levels of Tacrolimus in de Novo Renal Transplant Patients
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy and Safety of the Switch From Sirolimus to Everolimus in Stable Maintenance Renal Transplant Patients Receiving a Calcineurin Inhibitor Free Regimen
- Status
- COMPLETED
- Phase
- PHASE4
Efficacy and Safety of Everolimus With Enteric-Coated Mycophenolate Sodium (EC-MPS) in a Cyclosporine Microemulsion-free Regimen Compared to Standard Therapy in de Novo Renal Transplant Patients
- Status
- COMPLETED
- Phase
- PHASE4
Efficacy and Safety of Everolimus in de Novo Heart Transplant Recipients
- Status
- COMPLETED
- Phase
- PHASE3
Prevention of the Graft-Versus-Host-Disease in Patients After Stem Cell Transplantation With Tacrolimus and Everolimus
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
AEE788 and Everolimus in Treating Patients With Recurrent or Relapsed Glioblastoma Multiforme
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Everolimus in Treating Patients With Stage IV Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Safety/Efficacy of Everolimus and Neoral® in Adult Cardiac Transplant Patients With Established Allograft Vasculopathy
- Status
- COMPLETED
- Phase
- PHASE3
Gefitinib and Everolimus in Treating Patients With Stage IIIB or Stage IV or Recurrent Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Everolimus and Imatinib Mesylate in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia Who Are Not in Complete Cytogenetic Remission After Previous Imatinib Mesylate
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2